Literature DB >> 20229948

Comparison of LASIK and photorefractive keratectomy for myopia from -10.00 to -18.00 diopters 10 years after surgery.

Mohamad Rosman1, Jorge L Alió, Dolores Ortiz, Juan J Perez-Santonja.   

Abstract

PURPOSE: To compare the long-term outcomes of LASIK and photorefractive keratectomy (PRK) for high myopia (> or = -10.00 diopters [D]).
METHODS: This retrospective study included eyes with high myopia that underwent PRK (51 eyes) and LASIK (141 eyes) at the Instituto Oftalmologico de Alicante, Spain, and returned for 10-year follow-up.
RESULTS: Ten years after surgery, 45.5% of eyes in the LASIK group achieved uncorrected visual acuity (UCVA) of 20/40 or better compared to 31.3% in the PRK group. Mean efficacy indices after 10 years in both groups were similar (0.87 in the LASIK group and 0.82 in the PRK group, P=.51). Twenty-one (41%) eyes in the PRK group were within +/-1.00 D whereas 60 (42.5%) eyes from the LASIK group were within +/-1.00 D 10 years after surgery. Six (14%) eyes from the PRK group lost 2 or more lines of BSCVA compared to 7 (6%) eyes from the LASIK group.
CONCLUSIONS: LASIK and PRK have been shown to have similar visual acuity efficacy in the treatment of eyes with high myopia in the long-term, with LASIK having superior visual acuity efficacy and safety over PRK within the first 2 years after surgery. However, treatment of myopia > or =-10.00 D by LASIK is no longer routinely advocated whereas the treatment of high myopia by PRK is no longer performed due to potential complications associated with the treatment. Haze in postoperative PRK eyes was a significant long-term problem in our study. Copyright 2010, SLACK Incorporated.

Entities:  

Mesh:

Year:  2010        PMID: 20229948     DOI: 10.3928/1081597X-20100224-02

Source DB:  PubMed          Journal:  J Refract Surg        ISSN: 1081-597X            Impact factor:   3.573


  8 in total

1.  Matched optical quality comparison of 3-year results of PRK-MMC and phakic IOL implantation in the correction of high myopia.

Authors:  M Miraftab; H Hashemi; S Asgari
Journal:  Eye (Lond)       Date:  2015-05-15       Impact factor: 3.775

2.  Femtosecond laser-assisted LASIK versus PRK for high myopia: comparison of 18-month visual acuity and quality.

Authors:  Hassan Hashemi; Reza Ghaffari; Mohammad Miraftab; Soheila Asgari
Journal:  Int Ophthalmol       Date:  2016-10-03       Impact factor: 2.031

3.  Comparison of the visual outcomes between PRK-MMC and phakic IOL implantation in high myopic patients.

Authors:  H Hashemi; M Miraftab; S Asgari
Journal:  Eye (Lond)       Date:  2014-07-04       Impact factor: 3.775

Review 4.  Laser-assisted subepithelial keratectomy (LASEK) versus photorefractive keratectomy (PRK) for correction of myopia.

Authors:  Shi-Ming Li; Siyan Zhan; Si-Yuan Li; Xiao-Xia Peng; Jing Hu; Hua Andrew Law; Ning-Li Wang
Journal:  Cochrane Database Syst Rev       Date:  2016-02-22

5.  Comparison of laser in situ ketatomileusis and photorefractive keratectomy for myopia using a mixed-effects model.

Authors:  Yosai Mori; Kazunori Miyata; Takashi Ono; Yusuke Yagi; Kazutaka Kamiya; Shiro Amano
Journal:  PLoS One       Date:  2017-03-31       Impact factor: 3.240

6.  Refractive, visual, and subjective quality of vision outcomes for very high myopia LASIK from - 10.00 to - 13.50 diopters.

Authors:  Avi Wallerstein; Joseph Wai Keung Kam; Mathieu Gauvin; Eser Adiguzel; Mounir Bashour; Ananda Kalevar; Mark Cohen
Journal:  BMC Ophthalmol       Date:  2020-06-17       Impact factor: 2.209

7.  Implantable collamer lens versus small incision lenticule extraction for high myopia correction: A systematic review and meta-analysis.

Authors:  Kai Cao; Jingshang Zhang; Jinda Wang; Mayinuer Yusufu; Shanshan Jin; Shuying Chen; Ningli Wang; Zi-Bing Jin; Xiu Hua Wan
Journal:  BMC Ophthalmol       Date:  2021-12-27       Impact factor: 2.209

8.  Twelve-Month Outcomes of the Wavefront-Optimized Photorefractive Keratectomy for High Myopic Correction Compared with Low-to-Moderate Myopia.

Authors:  Napaporn Tananuvat; Pawara Winaikosol; Muanploy Niparugs; Winai Chaidaroon; Chulaluck Tangmonkongvoragul; Somsanguan Ausayakhun
Journal:  Clin Ophthalmol       Date:  2021-12-22
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.